Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach

Ali Ryan, Elena Polycarpou, Nathan A Lack, Dimitrios Evangelopoulos, Christian Sieg, Alice Halman, Sanjib Bhakta, Olga Eleftheriadou, Timothy D McHugh, Sebastian Keany, Edward D Lowe, Romain Ballet, Areej Abuhammad, William R Jacobs Jr, Alessio Ciulli, Edith Sim
  • British Journal of Pharmacology, May 2017, Wiley
  • DOI: 10.1111/bph.13810
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr ali ryan and Professor edith sim